Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway. [electronic resource]
Producer: 20200526Description: 146 p. digitalISSN:- 1475-2840
- ATP Binding Cassette Transporter 1 -- genetics
- Animals
- Blood Glucose -- drug effects
- Cholesterol -- blood
- Diabetes Mellitus -- blood
- Diet, High-Fat
- Disease Models, Animal
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Hep G2 Cells
- Hepatocytes -- drug effects
- Humans
- Hypoglycemic Agents -- pharmacology
- Incretins -- pharmacology
- Liraglutide -- pharmacology
- Liver -- drug effects
- Male
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Phosphorylation
- Signal Transduction
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.